Curcumin Oligosaccharides (Gluco-oligosaccharides) Penetrate the Blood-Brain Barrier in Mouse Brain: Glycoside (Polysaccharide) Modification Approach for Brain Drug Delivery Across the Blood-Brain Barrier and Tumor Drug Delivery

被引:5
|
作者
Hamada, Hiroki [1 ]
Nakayama, Takahiro [2 ]
Shimoda, Kei [3 ]
Matsuura, Nobuyasu [2 ]
Hamada, Hatsuyuki [4 ]
Iwaki, Takafumi [5 ]
Kiriake, Yuya [6 ]
Saikawa, Tomohiro [7 ]
机构
[1] Okayama Univ Sci, Fac Sci, Dept Life Sci, Okayama, Japan
[2] Kyorin Univ, Sch Med, Dept Med Physiol, Tokyo, Japan
[3] Oita Univ, Fac Med, Dept Biomed Chem, Oita, Japan
[4] Natl Inst Fitness & Sports Kanoya, Sch Phys Educ, Kagoshima, Japan
[5] Oita Univ, Fac Med, Dept Biophys, Oita, Japan
[6] Yamaguchi Univ, Fac Med & Hlth Sci, Yamaguchi, Japan
[7] Junshin Gakuen Univ, Dept Nursing, Fukuoka, Japan
关键词
drug delivery technique; blood-brain barrier; curcumin glucooligosaccharide; glycosylation; brain drug delivery; tumor drug delivery;
D O I
10.1177/1934578X20953653
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In order to expand our drug delivery technique by glycosylation of chemical into brain delivery, it was demonstrated that oligosaccharide and monosaccharide modifications of curcumin enhanced its crossing ability of the blood-brain barrier (BBB) in mice. The brain sample prepared by glycosidase-catalyzed hydrolysis of brain tissue homogenates of mice, to which curcumin gluco-oligosaccharides were intraperitoneally injected, contained curcumin at 116 ng/1 g of tissue of brain, indicating that curcumin modified with gluco-oligosaccharides residues can smoothly cross the BBB in mouse brain. The brain samples of mice, which were treated with curcumin monosaccharide or curcumin itself, contained curcumin at 18 ng and 0 ng per 1 g of tissue of brain, respectively. On the other hand, after the administration of curcumin gluco-oligosaccharides to C57131, mouse with a large tumor for 5 days, the tumor disappeared.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Strategies to Improve Drug Delivery Across the Blood-Brain Barrier
    Albertus G. de Boer
    Pieter J. Gaillard
    Clinical Pharmacokinetics, 2007, 46 : 553 - 576
  • [22] Strategies to improve drug delivery across the blood-brain barrier
    de Boer, Albertus G.
    Gaillard, Pieter J.
    CLINICAL PHARMACOKINETICS, 2007, 46 (07) : 553 - 576
  • [23] The physics of drug-delivery across the blood-brain barrier
    Guiot, C.
    Zullino, S.
    Priano, L.
    Cavalli, R.
    THERAPEUTIC DELIVERY, 2016, 7 (03) : 153 - 156
  • [24] Tumor necrosis factor and drug delivery in the blood-brain barrier
    Albensi, BC
    DRUG NEWS & PERSPECTIVES, 2002, 15 (04) : 233 - 237
  • [25] Brain Drug Delivery: Overcoming the Blood-brain Barrier to Treat Tauopathies
    Hanes, Jozef
    Lacova-Dobakova, Eva
    Majerova, Petra
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (13) : 1448 - 1465
  • [26] Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain
    Patel, Mayur M.
    Patel, Bhoomika M.
    CNS DRUGS, 2017, 31 (02) : 109 - 133
  • [27] In Vitro Models of the Blood-Brain Barrier for the Study of Drug Delivery to the Brain
    Wilhelm, Imola
    Krizbai, Istvan A.
    MOLECULAR PHARMACEUTICS, 2014, 11 (07) : 1949 - 1963
  • [28] Impacts of Blood-Brain Barrier in Drug Delivery and Targeting of Brain Tumors
    Omidi, Yadollah
    Barar, Jaleh
    BIOIMPACTS, 2012, 2 (01) : 5 - 22
  • [29] The blood-brain barrier choline transporter as a brain drug delivery vector
    Allen, DD
    Lockman, PR
    LIFE SCIENCES, 2003, 73 (13) : 1609 - 1615
  • [30] In vitro models of the blood-brain barrier to study drug delivery to the brain
    Couraud, Pierre-Olivier
    DRUG METABOLISM REVIEWS, 2009, 41 : 15 - 15